Home › NCT06919471
Assessing User Satisfaction and Adherence to an Abbreviated Dietary Tracking App (MySnackTracker) Versus Full-intake Dietary Monitoring
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Eligibility Criteria In order to be eligible to participate in this study, an participants must meet all of the following criteria: * Provision of signed and dated informed consent form * Access to internet connection, email address, and smartphone able to download the intervention app * Current or previous participation in one of the following DFI cohorts: PA17-0584 (MERIT Study), Project CHURCH, High Risk Breast Cohort, Mexican-American Cohort, and rural cancer survivors from the Mind Your BEAT study * Demonstrated ability to read and understand English. The study app is currently only available in English. Exclusion Criteria An participant who meets any of the following criteria will be excluded from participation in this study: * Prisoners * Anyone currently under 18 years of age * Cognitively impaired participants * Pregnant women (assessed by self-report) * BMI less than 28 or greater than 40 * Self-reported previous or planned bariatric surgery * Self-reported current or planned use of a GLP-1 agonist medication * Self-reported current or planned participation in another weight loss intervention * Cancer participants receiving active treatment * Anyone currently unable to participate in the research for the duration of the study * No current motivation to lose weight
About the study
To learn if a method of abbreviated food tracking (called MySnackTracker) is a reasonable alternative to traditional full-intake food tracking and to compare the adherence to and acceptability of each method.
What is being tested
- Fitbit (other)
- MySnackTracker App (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 90 · Started: Apr 8, 2025
Contact the study team
- Karen M Basen-Engquist, MD · Phone: 713-745-3123
Official record on ClinicalTrials.gov — NCT06919471
Locations in the U.S.
| Texas | MD Anderson Cancer Center, Houston |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.